Published in TB and Outbreaks Week, January 11th, 2000
MDR-TB is often fatal, causes chronic disabilities, and is infectious. "Cure rates of 96 percent have been achieved but require prompt recognition of the disease, rapid accurate susceptibility results, and early administration of an individualized re-treatment regimen," according to I. Bastian and colleagues, Institute of Tropical Medicine, Belgium.
Treatment regimens are usually based on a quinolone and an injectable...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.